Genmab — Marts 2017
-
God morgen.
-
Goodmorning, not sure this was posted on NCT02955810 Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA) (CyBorD-Dara) https://www.clinicaltrials.gov/ct2/show/NCT02955810?term=NCT02955810&rank=1
-
in Ireland https://www.nuigalway.ie/about-us/news-and-events/news-archive/2017/february2017/irish-patients-first-in-the-world-to-receive-drug-combination-as-part-of-blood-cancer-network-ireland-clinical-trial.html http://www.drugdevelopment-technology.com/news/newsnui-galway-initiates-phase-i-trial-of-daratumumab-in-irish-patients-with-multiple-myeloma-5750136
-
@ transalp Tak for videoen. Den har vist ikke været linket før. Særdeles positivt, at der er så meget opmærksomhed på dara-resistente patienter. Fase 2 studiet, som van de Donk omtaler har præliminære data allerede nu i maj. https://www.clinicaltrials.gov/ct2/show/NCT02751255?term=daratumumab+atra&rank=1
-
@CPH Når du klikker på 'svenska Handelsbanken AB' som største køber kan du se 'efternavnet' (SHD) og (SVB). Du har ret,
det ser mærkeligt ud at de ikke handler ens.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind